The British In Vitro Diagnostics Association (BIVDA) has today (25 October) launched its new report examining “The Value of IVDs”.
The eight page report examines how in vitro diagnostics (IVDs) are delivering value for patients, the NHS and the UK economy. The document is supported by a range of case studies focused around three key themes:
- Improvement: Empowering patients for better outcomes, diagnosis and treatment
- Impact: Increasing efficiencies and savings within the NHS
- Investment: Contribution To The UK economy
Within these themes, the case studies cover a wide range of topics including antimicrobial resistance, screening, early diagnosis and wound care. The report also identifies five key recommendations for change to ensure the continuing success of the IVD industry in a post-Brexit landscape.
Commenting on the report, Doris-Ann Williams MBE, Chief Executive of BIVDA, said:
“The contribution of IVDs to the health and wealth of our nation should not be underestimated. Approximately 70% of clinical decisions are made using IVDs but despite the differences they can make to patient pathways, a glass ceiling remains when it comes to adoption and uptake across the NHS.
“Through this report, we hope to clearly demonstrate the tangible benefits that IVDs are already delivering for patients, the NHS and the UK economy. If IVDs were adopted more widely, we would be able to build on this progress and provide better outcomes for all”.
The Value of IVDs is available to download from the BIVDA website.- The Value of IVDs, The Value Story Case Studies